LAVAL, QC, April 1, 2014 /CNW Telbec/ - Ergoresearch Ltd « Ergoresearch » (TSX Venture Exchange: ERG) is proud to announce the nomination of Mr. Piero Greco as its new Chief Financial Officer in the management team of the company. Mr. Greco will be assisted by Mrs. Dominique Boudreau, who will now act as the group's Corporate Controller. Mme Boudreau held the same position the last seven years for Laboratoire Langelier, a company acquired by Ergoresearch Ltd in January 2013.
M. Greco is a member of The Chartered Professional Accountants and has accumulated many years of experience in corporate financing, treasury, administration and in merging and acquisition, for different companies, in services and manufacturing, working in Québec, Canada and at the international.
"Mr. Greco strengthens the management team already in place and brings extensive expertise in mergers and acquisitions with over thirty closing. He also carried out a number of negotiation at the international level and stood out as a proficient manager of human, material and financial resources. With the separation of the Controller and the Chief Financial Officer positions, the company has given itself the means to perform the next steps in its growth plan." mention Sylvain Boucher, President and CEO of Ergoresearch Ltd.
And Mr. Greco added: "Ergoresearch has built a unique platform in the orthopedic market. This structure offers interesting levers and a perspective of significant growth. I look forward to join the team in place to continue and contribute to the future development of the Company."
Ergoresearch has developed Quebec's leading network in orthotics, with over 100 corporate and satellite centres under the Clinique du pied Équilibre, Orthoconcept and Laboratoire Langelier banners. The Company holds patents in the field of bionics including intellectual property used in the Power Knee, the world's only motor-powered prosthesis for above-knee amputees, and is the leading manufacturer of "intelligent" foot orthotics and specialty orthotics, it is a trend-setter in creating durable medical equipment and software in the orthopedics market.
Ergoresearch has developed and commercialized Expert-Fit™, the first robotized custom-fit orthotics manufacturing software program, launched the first Living Lab in Canada and more recently, a new generation of world -patented orthotic device called the OdrA, that revolutionizes the treatment of pain associated with knee osteoarthritis. Ergoresearch Ltd is listed on the TSX Venture Exchange (TSXV) under the symbol ERG.
This document is not intended to encourage the purchase of securities listed on the TSX Venture Exchange. TMX Group, and the members of the same group, do not endorse or recommend the title referred to herein. Please seek the advice of a specialist to evaluate specific securities.
This press release contains forward-looking statements and information that are subject to material risks and uncertainties. Such statements are not historical facts and are based on current management expectations. We ask the reader to note that these statements are subject to a multitude of risks and uncertainties that could cause actual results, future circumstances or events to differ materially from those contained in the forward-looking. These risk factors are related, but are not limited to, our ability to finance our operations, competition, the ability to negotiate and maintain up alliances with partners, the market acceptance of the Company's products, the strength of intellectual property, the success of our research and development programs, reliance on subcontractors and their key personnel and other risks and uncertainties detailed from time to time in other documents we file with the Canadian securities commissions and are available at www.sedar.com.
The reader should not give great importance to forward-looking statements as the results may differ from conclusions, predictions or projections contained in such forward-looking statements; and certain important factors or hypothesis taken into account in reaching conclusions or the preparation of a projection or prediction may prove to be incorrect in fact.
Management disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or circumstances. All figures are in Canadian dollars, unless otherwise specified.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Image with caption: "Nomination of the new Chief Financial Officer: Mr. Piero Greco, MBA, CPA, CA, Ergoresearch Ltd (CNW Group/Ergoresearch Ltd)". Image available at: http://photos.newswire.ca/images/download/20140401_C8095_PHOTO_EN_38688.jpg
SOURCE: Ergoresearch Ltd
For further information:
Sylvain Boucher, Président et chef de la direction - Ergoresearch Ltd
Tel. : 450-973-6700, poste 213 / email@example.com
Émilie Vion, coordonnatrice communications - Ergoresearch Ltd
Tél. : 450-973-6700, poste 242 / firstname.lastname@example.org